Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -1.16% |
| 2024 | -3.79% |
| 2023 | -14.15% |
| 2022 | -18.32% |
| 2021 | 30.37% |
| 2020 | 81.41% |
| 2019 | 321.17% |
| 2018 | 0.00% |